1 |
보건복지부, 2002년 한국암등록사업 연례보고서 (2002)
|
2 |
통계청, 인구 100,000명당 주요 암 사망률 (2002)
|
3 |
이의경 : 약물치료학 제8장 의약품 경제성평가, 신일상사, 서울 (2006)
|
4 |
Drummond, M. F., Sculpher, M. J., Torrance, G. W., O'Brien, B. J. and Stoddart, G. L. : Methods for the economic evaluation of health care programmes. 3rd ed. 205 (2005)
|
5 |
Norum, J. and Angelsen, V. : Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens. Journal of Chemotherapy 7(5), 455 (1995)
DOI
|
6 |
Daly, E., Gray, A., Barlow, D., McPherson, K., Roche, M. and Vessey, M. : Measuring the impact of menopausal symptoms on quality of life. BMJ 307(2), 836 (1993)
DOI
ScienceOn
|
7 |
Milne, R. J., Heaton-Brown, K. H., Hansen, P., Thomas, D., Harvey, V. and Cubitt, A. : Quality-of-life valuations of advanced breast cancer by New Zealand Women. Pharmacoeconomics 24(3), 281 (2006)
DOI
ScienceOn
|
8 |
Drummond, M. F., O'Brien B. J., Stoddart, G. L. and Torrance, G. W. : Methods for the economic evaluation of health care programmes 2nd ed. (1997)
|
9 |
박조현 : 위암가이드북, (주)국일미디어, 경기 (2007)
|
10 |
Wu, X., Chen, V. W., Andrews, P. A., Ruiz, B. and Correa, P. : Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control 18(6), 585 (2007)
DOI
ScienceOn
|
11 |
Wildi, S. M., Cox, M. H., Clark, L. L., Tuner, R., Hawes, R. H., Hoffman, B. J. and Wallace, M. B. : Assessment of health state utilities and quality of life in patients with malignant esophageal dysphagia. American Journal of Gastroenterology 1044 (2004)
|
12 |
Kopec, J. A. and Willison, K. D. : A comparative review of four preference-weighted measures of health-related quality of life. Journal of Clinical Epidemiology 56, 317 (2003)
DOI
ScienceOn
|